plus History

WebmedCentral (www.webmedcentral.com, also known as WMC) is a unique platform that publishes biomedical scientific content without any pre-publication peer review. That there was a need for such a platform became obvious when within a short time span, there are already  more than 6000 registered users and 1300 articles have been published.

While WMC continues to report healthy growth, we have observed that a significant body of scientists feel uneasy about publishing their work on our portal. Their reluctance stems from a perceived lack of quality control on WMC. The perceived role of pre-publication peer review as a surrogate marker for academic proficiency is important for them to attract grants and carry out further research. It is crucial for their academic progress and career progression. Indexation of their research with various databases and citation tracking bodies that will only include "Peer Reviewed" literature is very important for visibility of their research.

We at WMC have noted all these concerns and have initiated "plus", which will publish research only after peer review and hopefully will be recognised as such by various databases and considered in future for an impact factor. At the same time, our main portal WMC will continue to function as usual. We will continue to work to ensure that it has a robust multi layered "post publication peer review" system and we have recently introduced several changes to make it function better.

With our twin portals, www.webmecentral.com (also known as WMC) and www.webmedcentralplus.com (also known as plus), we aim to cater to all scientists irrespective of their preference for the pre- or post publication peer review model. Scientists who want the independence of publishing without pre-publication peer review and value the timely delivery of their message that it provides at a very low cost will continue to be able to use WMC. On the other hand scientists, who want to publish via a pre-publication peer review platform because they value the feedback of reviewers prior to publication or because they have to do so to protect their own interests or that of the institution they work for, will now be able to use plus.